Search

Your search keyword '"Yang, Shun'e"' showing total 13 results
Start Over Author "Yang, Shun'e"
13 results on '"Yang, Shun'e"'

1. Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

Author

Song, Yuqin, Zhou, Hui, Zhang, Huilai, Liu, Wei, Shuang, Yuerong, Zhou, Keshu, Lv, Fangfang, Xu, Hao, Zhou, Jianfeng, Li, Wei, Wang, Huaqing, Zhang, Hongyu, Huang, Haiwen, Zhang, Qingyuan, Xu, Wei, Ge, Zheng, Xiang, Ying, Wang, Shuye, Gao, Da, Yang, Shun’e, Lin, Jinying, Wang, Lin, Zou, Liqun, Zheng, Meifang, Liu, Jing, Shao, Zonghong, Pang, Ying, Xia, Ruixiang, Chen, Zhendong, Hou, Ming, Yao, Hongxia, Feng, Ru, Cai, Zhen, Zhang, Mingzhi, Ran, Wenhua, Liu, Lin, Zeng, Shan, Yang, Wei, Liu, Peng, Liang, Aibin, Zuo, Xuelan, Zou, Qingfeng, Ma, Junxun, Sang, Wei, Guo, Ye, Zhang, Wei, Cao, Yongqing, Li, Yan, Feng, Jifeng, Du, Xin, Zhang, Xiaohong, Zhao, Hongguo, Zhou, Hui, Yu, Jie, Sun, Xing, Zhu, Jun, and Qiu, Lugui

Published
2021
Full Text
View/download PDF

4. sj-docx-1-tam-10.1177_17588359221122715 – Supplemental material for A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer

Author

Yan, Min, Yuan, Peng, Ouyang, Quchang, Cheng, Ying, Han, Guohui, Wang, Dewei, Ran, Li, Sun, Tao, Zhao, Da, Bai, Yuju, Yang, Shun’e, Wang, Xiaojia, Wu, Rong, Zeng, Xiaohua, Yao, Herui, Ji, Xuening, Jiang, Jun, Hu, Xiaohua, Lin, Haifeng, Zheng, Liping, Zhu, Zhitu, Ge, Wei, Yang, Junlan, Cui, Tongjian, Zhang, Xiaozhi, Lu, Fangyang, Li, Wenhui, Xu, Hongyan, Kang, Mafei, Gong, Ping, Zou, Liqun, Liu, Jiang, Zhang, Hongliang, Yu, Hao, and Xu, Binghe

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-docx-1-tam-10.1177_17588359221122715 for A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer by Min Yan, Peng Yuan, Quchang Ouyang, Ying Cheng, Guohui Han, Dewei Wang, Li Ran, Tao Sun, Da Zhao, Yuju Bai, Shun’e Yang, Xiaojia Wang, Rong Wu, Xiaohua Zeng, Herui Yao, Xuening Ji, Jun Jiang, Xiaohua Hu, Haifeng Lin, Liping Zheng, Zhitu Zhu, Wei Ge, Junlan Yang, Tongjian Cui, Xiaozhi Zhang, Fangyang Lu, Wenhui Li, Hongyan Xu, Mafei Kang, Ping Gong, Liqun Zou, Jiang Liu, Hongliang Zhang, Hao Yu and Binghe Xu in Therapeutic Advances in Medical Oncology

Published
2022
Full Text
View/download PDF

5. A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer

Author

Yan, Min, primary, Yuan, Peng, additional, Ouyang, Quchang, additional, Cheng, Ying, additional, Han, Guohui, additional, Wang, Dewei, additional, Ran, Li, additional, Sun, Tao, additional, Zhao, Da, additional, Bai, Yuju, additional, Yang, Shun’e, additional, Wang, Xiaojia, additional, Wu, Rong, additional, Zeng, Xiaohua, additional, Yao, Herui, additional, Ji, Xuening, additional, Jiang, Jun, additional, Hu, Xiaohua, additional, Lin, Haifeng, additional, Zheng, Liping, additional, Zhu, Zhitu, additional, Ge, Wei, additional, Yang, Junlan, additional, Cui, Tongjian, additional, Zhang, Xiaozhi, additional, Lu, Fangyang, additional, Li, Wenhui, additional, Xu, Hongyan, additional, Kang, Mafei, additional, Gong, Ping, additional, Zou, Liqun, additional, Liu, Jiang, additional, Zhang, Hongliang, additional, Yu, Hao, additional, and Xu, Binghe, additional

Published
2022
Full Text
View/download PDF

10. Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure

Author

Hu, Shaoxuan, primary, Song, Yuqin, additional, Sun, Xiuhua, additional, Su, Liping, additional, Zhang, Wei, additional, Jia, Jing, additional, Bai, Ou, additional, Yang, Sheng, additional, Liang, Rong, additional, Li, Xiaoling, additional, Zhang, Huilai, additional, Gao, Yuhuan, additional, Zhang, Weijing, additional, Xiao, Xiubin, additional, Bao, Huizheng, additional, Wang, Ningju, additional, Ren, Hanyun, additional, Cen, Xinan, additional, Yang, Shun'e, additional, Zhao, Yu, additional, Wang, Yinan, additional, Wang, Yalan, additional, Liu, Aichun, additional, Wang, Jingwen, additional, Shi, Yuankai, additional, Yuan, Ming, additional, Li, Yufu, additional, and He, Xiaohui, additional

Published
2018
Full Text
View/download PDF

12. Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS)

Author

Hu, Shaoxuan, primary, Song, Yuqin, additional, Li, Yufu, additional, Sun, Xiuhua, additional, Su, Liping, additional, Zhang, Wei, additional, Jia, Jing, additional, Bai, Ou, additional, Liang, Rong, additional, Li, Xiaoling, additional, Zhang, Huilai, additional, Gao, Yuhuan, additional, Zhang, Weijing, additional, Xiao, Xiubin, additional, Bao, Huizheng, additional, Wang, Ningju, additional, Ren, Hanyun, additional, Cen, Xinan, additional, Yang, Shun'e, additional, Zhao, Yu, additional, Wang, Yinan, additional, Wang, Yalan, additional, Liu, Aichun, additional, Wang, Jingwen, additional, Shi, Yuankai, additional, Yuan, Ming, additional, and He, Xiaohui, additional

Published
2016
Full Text
View/download PDF

13. Increased Risk of Lymphoma in Men or the Elderly Infected with Tuberculosis.

Author

Li G, Chen GL, Zhou Y, Yao GQ, Yang S, and Ji DM

Abstract

Purpose: To identify factors associated with lymphoma in patients with prior Mycobacterium tuberculosis infection., Methods: A retrospective case-control analysis was performed in a highly tuberculosis (TB)-endemic area. Patients with a history of TB before the diagnosis of lymphoma were retrospectively identified. Inpatients with lymphoma (n=1,057) and pathologically confirmed benign diseases (n=12,916) were consecutively enrolled at Xinjiang Medical University Cancer Hospital between January 2016 and December 2019., Results: The proportion of TB infection in patients with lymphoma (n=148, 14.0%) was significantly higher than that in the control (benign diseases) group (n=175, 1.4%) (p<0.0001). The frequencies of TB infection in patients with Hodgkin lymphoma, B-cell non-Hodgkin lymphoma (NHL), and T/NK-cell NHL were 13.6%, 14.6%, and 11.9%, respectively. Relatively high proportions of TB infection were found in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell lymphoma (MZBL), and diffuse large B-cell lymphoma (DLBCL), at 20.6%, 18.6% and 15.3%, respectively, compared to other subtypes of B-cell NHL. For T/NK-cell NHL, the proportions of TB infection in patients with peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS), and anaplastic large cell lymphoma (ALCL) were 18.2% and 20%, respectively. The multivariate analysis revealed that male sex was an adverse risk factor for lymphoma after tubercular infection. In addition, male sex and older age (>60 years) were associated with B-cell NHL., Conclusion: A high proportion of TB infection was found in patients with lymphoma. In TB-infected patients, older age and male sex were associated with susceptibility to lymphoma, suggesting that screening programmes might be useful for the early detection of lymphoma. Keywords Lymphoma; tuberculosis; Burkitt's lymphoma; diffuse large B lymphoma; Hodgkin's disease., Competing Interests: Competing interests: The authors declare no conflict of Interest.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results